Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) has scheduled the release of its second quarter 2026 financial results for Wednesday, July 29, 2026, after the close of U.S. markets. The company will also host a live conference call and webcast at 5:00 p.m. U.S. EDT on the same day to discuss the results and provide a business update.
Conference Call and Webcast Details
All financial materials, including the earnings release and presentation, will be made available on the Investor Relations section of the Bausch Health website before the call begins. The webcast can be accessed at http://ir.bauschhealth.com/events-and-presentations. A replay of the conference call will be posted on the same website following the event.
About Bausch Health
Bausch Health Companies Inc. is a global diversified pharmaceutical company that develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals, and eye health. The company holds a controlling interest in Bausch + Lomb. Bausch Health states its ambition is to be a globally integrated healthcare company trusted and valued by patients, healthcare professionals, employees, and investors. More information is available at www.bauschhealth.com and on LinkedIn.
Investor and Media Contacts
Investor inquiries can be directed to Garen Sarafian at ir@bauschhealth.com or toll-free at (877) 281-6642. Media inquiries should be directed to Katie Savastano at corporate.communications@bauschhealth.com or (908) 541-3785. The press release is identified as BHC-FINANCIAL.
